Futureworld (OTCMKTS:FWDG) and Nano-X Imaging (NASDAQ:NNOX) Head to Head Contrast

Futureworld (OTCMKTS:FWDGGet Free Report) and Nano-X Imaging (NASDAQ:NNOXGet Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Valuation & Earnings

This table compares Futureworld and Nano-X Imaging”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Futureworld N/A N/A N/A N/A N/A
Nano-X Imaging $13.02 million 5.02 -$75.02 million ($1.58) -0.59

Futureworld has higher earnings, but lower revenue than Nano-X Imaging.

Profitability

This table compares Futureworld and Nano-X Imaging’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Futureworld N/A N/A N/A
Nano-X Imaging -716.44% -70.96% -62.26%

Analyst Recommendations

This is a summary of current ratings for Futureworld and Nano-X Imaging, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Futureworld 0 0 0 0 0.00
Nano-X Imaging 1 2 2 1 2.50

Nano-X Imaging has a consensus target price of $4.33, suggesting a potential upside of 364.15%. Given Nano-X Imaging’s stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Futureworld.

Volatility and Risk

Futureworld has a beta of -0.12, meaning that its share price is 112% less volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500.

Insider and Institutional Ownership

21.5% of Nano-X Imaging shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Nano-X Imaging beats Futureworld on 7 of the 10 factors compared between the two stocks.

About Futureworld

(Get Free Report)

FutureWorld Corp., together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of hemp/cannabis products, services, and technologies worldwide. The company provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation, and consultation for the industrial hemp and legal medicinal marijuana. It offers personal and professional tetrahydrocannabinoil and Cannabidiol test kits; pharmaceutical grade CBD oil solutions; URVape vaporizer pens, which are oil vaporizers for the e-cigarette, cannabis, and herbal vaping industry; CaNNaLyTiX, a dashboard controller system that allows various computer systems to be integrated throughout a cultivator's infrastructures; CaNNaTRAK, the barcode and RFID tracking systems for keeping seed to sale tracking of hemp/cannabis; and SPIDer (secure perimeter intrusion detection network), a system to meet the needs of theft and malicious attacks. The company also provides SmartSense, which offers wireless security and smart sensor mesh network for precision agriculture, irrigation systems, and greenhouses for the hemp industry; SmartNergy that offers tools to analyze various aspects of a cultivator's energy usage; and CaNNaBoX machine, which operates with the swipe of a card to verify identity, age, and prescription information of a medical marijuana patient before releasing measured packages of marijuana. Its target customers include consumers via Internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, affiliate sales, and master distributors. The company was formerly known as FutureWorld Energy, Inc. and changed its name to FutureWorld Corp. in June 2014. FutureWorld Corp. was founded in 2002 and is based in Saint Petersburg, Florida.

About Nano-X Imaging

(Get Free Report)

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Receive News & Ratings for Futureworld Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futureworld and related companies with MarketBeat.com's FREE daily email newsletter.